Published in J Immunol on February 01, 1985
A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med (1995) 2.88
Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirus. Nature (1986) 2.64
Differential inhibition of IL-1 and TNF-alpha mRNA expression by agents which block second messenger pathways in murine macrophages. J Immunol (1988) 1.55
Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. J Natl Cancer Inst (1989) 1.44
Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J Biol Chem (1997) 1.33
Macrophage-colony-stimulating factor (CSF-1) induces proliferation, chemotaxis, and reversible monocytic differentiation in myeloid progenitor cells transfected with the human c-fms/CSF-1 receptor cDNA. Proc Natl Acad Sci U S A (1990) 1.31
A murine macrophage cell line, immortalized by v-raf and v-myc oncogenes, exhibits normal macrophage functions. Eur J Immunol (1987) 1.25
Genetic resistance/susceptibility to mycobacteria: phenotypic expression in bone marrow derived macrophage lines. J Leukoc Biol (1991) 1.24
Expression and role of p75 interleukin 2 receptor on human monocytes. J Exp Med (1990) 1.19
Potential requirement of a functional double-stranded RNA-dependent protein kinase (PKR) for the tumoricidal activation of macrophages by lipopolysaccharide or IFN-alpha beta, but not IFN-gamma. J Immunol (1995) 1.17
Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7. J Exp Med (1995) 1.14
Transforming growth factor beta downregulates interleukin-1 (IL-1)-induced IL-6 production by human monocytes. Blood (1990) 1.13
Flavopiridol, a protein kinase inhibitor, down-regulates hypoxic induction of vascular endothelial growth factor expression in human monocytes. Cancer Res (1999) 1.12
Interferon activates macrophages to produce plasminogen activator. J Interferon Res (1982) 1.11
Endotoxin requirement for macrophage activation by lymphokines in a rapid microcytotoxicity assay. J Immunol Methods (1980) 1.10
Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1. Infect Immun (1990) 1.10
Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem Biophys Res Commun (1996) 1.08
Pleiotropic effects of transforming growth factor-beta on cells of the immune system. Ann N Y Acad Sci (1993) 1.05
Interferon-gamma upregulates interleukin-8 gene expression in human monocytic cells by a posttranscriptional mechanism. Blood (1994) 1.05
Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity. J Immunol (1992) 1.05
IL-2 induces IL-6 production in human monocytes. J Immunol (1992) 1.03
IL-2 up-regulates but IFN-gamma suppresses IL-8 expression in human monocytes. J Immunol (1993) 1.02
Cytokine gene expression during the generation of human lymphokine-activated killer cells: early induction of interleukin 1 beta by interleukin 2. Cancer Res (1989) 1.02
Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus. Cancer Biochem Biophys (1989) 1.01
Regulation of inducible nitric oxide synthase expression in IFN-gamma-treated murine macrophages cultured under hypoxic conditions. J Immunol (1996) 1.00
Posttranscriptional control of human gamma interferon gene expression in transfected mouse fibroblasts. Mol Cell Biol (1986) 0.99
c-fos mRNA expression in macrophages is downregulated by interferon-gamma at the posttranscriptional level. Mol Cell Biol (1991) 0.98
The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and -1 beta in macrophages. J Immunol (2000) 0.97
Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes. Blood (1994) 0.97
Mechanisms of lymphocyte activation: linkage between early protein synthesis and late lymphocyte proliferation. J Immunol (1980) 0.97
Potent activation of mouse macrophages by recombinant interferon-gamma. Cancer Res (1984) 0.96
Macrophages as regulators of immune responses against tumors. Adv Exp Med Biol (1979) 0.96
Characterization of IL-2 receptor expression and function on murine macrophages. J Immunol (1990) 0.96
Regulation of nitric-oxide synthase mRNA expression by interferon-gamma and picolinic acid. J Biol Chem (1994) 0.95
Augmentation of c-fos mRNA expression by activators of protein kinase C in fresh, terminally differentiated resting macrophages. Mol Cell Biol (1987) 0.93
A functional protein kinase C is required for induction of 2-5A synthetase by recombinant interferon-alpha A in Daudi cells. J Biol Chem (1989) 0.93
The effect of cytochalasin B, colchicine and vinblastine on the adhesion of Trichomonas vaginalis to glass surfaces. Int J Parasitol (1975) 0.92
Interleukin-2 and human monocyte activation. J Leukoc Biol (1995) 0.90
Tumoricidal alveolar macrophage and tumor infiltrating macrophage cell lines. Int J Cancer (1991) 0.90
Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562. Cancer Res (1987) 0.90
An electrogenic amino acid transporter in the apical membrane of cultured human bronchial epithelial cells. Am J Physiol (1998) 0.90
Lipopolysaccharide, but not IFN-gamma, down-regulates c-fms mRNA proto-oncogene expression in murine macrophages. J Immunol (1990) 0.89
Inhibition of retroviral mRNA expression in the murine macrophage cell line GG2EE by biologic response modifiers. J Immunol (1988) 0.89
Picolinic acid, a catabolite of L-tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages. J Immunol (1993) 0.87
Interferon-alpha, -beta, and -gamma augment the levels of rRNA precursors in peritoneal macrophages but not in macrophage cell lines and fibroblasts. J Immunol (1987) 0.87
IL-2 enhances c-fms expression in human monocytes. J Immunol (1990) 0.86
Engineering of macrophages to produce IFN-gamma in response to hypoxia. J Immunol (2001) 0.86
In vivo activation of macrophages but not natural killer cells by picolinic acid (PLA). J Immunopharmacol (1984) 0.85
IL-4 inhibits the costimulatory activity of IL-2 or picolinic acid but not of lipopolysaccharide on IFN-gamma-treated macrophages. J Immunol (1991) 0.85
Generation of a murine monoclonal antibody that detects the fos oncogene product. Anal Biochem (1987) 0.85
Inhibition of replication of virus-transformed fibroblasts by antibodies to RNA. Cancer Res (1975) 0.85
IL-4 and IL-13 induce Lsk, a Csk-like tyrosine kinase, in human monocytes. J Exp Med (1994) 0.85
Requirement for protein synthesis for induction of macrophage tumoricidal activity by IFN-alpha and IFN-beta but not by IFN-gamma. J Immunol (1984) 0.84
Functional role for the myeloid differentiation antigen CD14 in the activation of human monocytes by IL-2. J Immunol (1997) 0.84
Comparison of five short-term assays that measure nonspecific cytotoxicity mediated to tumor cells by activated macrophages. J Leukoc Biol (1986) 0.84
Regulation by interleukin-2 (IL-2) and interferon gamma of IL-2 receptor gamma chain gene expression in human monocytes. Blood (1994) 0.84
Regulation of IL-2 receptor subunit genes in human monocytes. Differential effects of IL-2 and IFN-gamma. J Immunol (1992) 0.83
IL-2 induction of IL-1 beta mRNA expression in monocytes. Regulation by agents that block second messenger pathways. J Immunol (1989) 0.83
Suppression of proliferative response and lymphokine production during the progression of a spontaneous tumor. Cancer Res (1979) 0.83
Induction of macrophage glutamine: fructose-6-phosphate amidotransferase expression by hypoxia and by picolinic acid. Int J Immunopathol Pharmacol (2007) 0.83
Role of protein synthesis in the activation of cytotoxic mouse macrophages by lymphokines. Cell Immunol (1984) 0.83
New high-performance liquid chromatographic method for the detection of picolinic acid in biological fluids. J Chromatogr B Biomed Sci Appl (2001) 0.83
Antiproliferative activity of picolinic acid due to macrophage activation. Drugs Exp Clin Res (1987) 0.83
Systemic and in situ natural killer and suppressor cell activities in mice bearing progressively growing murine sarcoma-virus-induced tumors. Int J Cancer (1981) 0.82
Human Harvey-ras is biochemically different from Kirsten- or N-ras. Oncogene (1991) 0.82
Selective inhibition by monosaccharides of tumor cell cytotoxicity mediated by mouse macrophages, macrophage-like cell lines, and natural killer cells. Int J Cancer (1983) 0.82
Metabolic requirements for the in vitro augmentation of mouse natural killer activity by interferon. Cell Immunol (1981) 0.82
Distribution of peritoneal macrophage populations after intravenous injection in mice: differential effects of eliciting and activating agents. J Reticuloendothel Soc (1983) 0.82
Mechanism of lymphocyte activation. II. Requirements for macromolecular synthesis in the production of lymphokines. J Immunol (1980) 0.82
Divergent effects of dithiocarbamates on AP-1-containing and AP-1-less NFAT sites. Eur J Immunol (1999) 0.81
Protein kinase C inhibitors block the activation of macrophages by IFN-beta but not by IFN-gamma. J Immunol (1988) 0.81
Prostaglandins inhibit lipoprotein lipase gene expression in macrophages. Immunology (1994) 0.80
Immortalization of macrophages from mouse bone marrow and fetal liver. Exp Cell Res (1990) 0.80
Modulation of CD3- large granular lymphocyte functions by agonist and antagonists of protein kinase C: effects on NK and lymphokine-activated killer activity and production of IFN-gamma. J Immunol (1989) 0.80
Depletion of macrophages from heterogeneous cell populations by the use of carbonyl iron. Methods Enzymol (1984) 0.79
In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation. J Immunol (1981) 0.79
Expression of protein kinase C-alpha (PKC-alpha) and MYCN mRNAs in human neuroblastoma cells and modulation during morphological differentiation induced by retinoic acid. FEBS Lett (1991) 0.79
Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS. J Immunol (1981) 0.79
Selective inhibition of 28S ribosomal RNA in macrophages activated by interferon-gamma or -beta. J Immunol (1987) 0.79
Expression of human immunodeficiency virus long terminal repeat in the human promonocyte cell line U937: effect of endotoxin and cytokines. Cell Immunol (1990) 0.79
IL-4 inhibits IL-2-induced tumoricidal activity and secretory functions of human monocytes. Modulation of IL-2 binding and IL-2 receptor beta gamma chain expression. J Immunol (1995) 0.79
Suppression of lymphokine production. I. Macrophage-mediated inhibition of MIF production. Cell Immunol (1980) 0.79
Regulation of lymphocyte activation: macrophage-dependent suppression of T lymphocyte protein synthesis. J Immunol (1980) 0.78
Immunobiology of picolinic acid. Adv Exp Med Biol (1996) 0.78
Down regulation of RNA labeling as a selective marker for cytotoxic but not suppressor macrophages. J Immunol (1984) 0.78
Inhibitory cytokine circuits involving transforming growth factor-beta, interferon-gamma, and interleukin-2 in human monocyte activation. Blood (1994) 0.78
Newborn liver gene transfer by an HIV-2-based lentiviral vector. Gene Ther (2005) 0.78
LPS-inducible nuclear factor in human monocytes that binds the negative regulatory element of the HIV LTR. J Leukoc Biol (1994) 0.78
The Csk-like proteins Lsk, Hyl, and Matk represent the same Csk homologous kinase (Chk) and are regulated by stem cell factor in the megakaryoblastic cell line MO7e. Growth Factors (1997) 0.78
A microsystem to evaluate the synthesis of [3H]leucine labeled proteins by macrophages. J Immunol Methods (1980) 0.77
Morphological change and cellular differentiation induced by cisplatin in human neuroblastoma cell lines. Cancer Chemother Pharmacol (1989) 0.77
Suppression of lymphokine production: II. Macrophage-dependent inhibition of production of macrophage activating factor. Cell Immunol (1981) 0.77
Molecular bases for macrophage activation. Ann Inst Pasteur Immunol (1986) 0.77
Regulation of taurine transport in murine macrophages. Amino Acids (2001) 0.77
Tumor formation by a murine macrophage cell line immortalized in vitro by v-raf and v-myc oncogenes. Cancer Immunol Immunother (1988) 0.77
Differential in vitro modulation of suppressor and antitumor functions of mouse macrophages by lymphokines and/or endotoxin. Cell Immunol (1988) 0.76
Leukemia inhibitory factor induces interleukin-8 and monocyte chemotactic and activating factor in human monocytes: differential regulation by interferon-gamma. Blood (1995) 0.76
Generation of high-titer retroviral vector-producing macrophages as vehicles for in vivo gene transfer. Gene Ther (2001) 0.76